newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference

DEVON, Pa., April 05, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders,